BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1341628)

  • 1. Antibiotic prophylaxis and prosthetic valve endocarditis.
    Antunes MJ; Sanches MF; Fernandes LE
    J Heart Valve Dis; 1992 Nov; 1(2):201-5. PubMed ID: 1341628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
    Wareham DW; Abbas H; Karcher AM; Das SS
    J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS; McDermott BP; Cunha BA
    Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of Staphylococcus epidermidis prosthetic valve endocarditis with linezolid after failure of treatment with oxacillin, gentamicin, rifampicin, vancomycin, and fusidic acid regimens.
    de Feiter PW; Jacobs JA; Jacobs MJ; Vink C; van der Geest S
    Scand J Infect Dis; 2005; 37(3):173-6. PubMed ID: 15849048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic pretreatment of heart valve prostheses to prevent early prosthetic valve endocarditis.
    Mashaqi B; Marsch G; Shrestha M; Graf K; Stiesch M; Chaberny IF; Haverich A; Kuehn C
    J Heart Valve Dis; 2011 Sep; 20(5):582-6. PubMed ID: 22066364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pathogenic factors on prognosis in patients with prosthetic valve endocarditis.
    Abramczuk E; Hryniewiecki T; Stepińska J
    Kardiol Pol; 2007 Feb; 65(2):115-22; discussion 123-4. PubMed ID: 17366355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prosthetic valve endocarditis. Experience with porcine bioprostheses.
    Sett SS; Hudon MP; Jamieson WR; Chow AW
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):428-34. PubMed ID: 8445921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of once-daily vancomycin for staphylococcal endocarditis.
    Marik PE
    Pharmacotherapy; 1998; 18(3):650-2. PubMed ID: 9620118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for prophylaxis against prosthetic valve endocarditis: a review article.
    Hyde JA; Darouiche RO; Costerton JW
    J Heart Valve Dis; 1998 May; 7(3):316-26. PubMed ID: 9651846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocarditis due to coagulase-negative staphylococci. Microbiologic, epidemiologic, and clinical considerations.
    Whitener C; Caputo GM; Weitekamp MR; Karchmer AW
    Infect Dis Clin North Am; 1993 Mar; 7(1):81-96. PubMed ID: 8463655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aortic homograft implantation in severe endocarditis].
    Foghsgaard S; Bruun NE; Kjaergård HK
    Ugeskr Laeger; 2008 May; 170(19):1646-50. PubMed ID: 18489875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes.
    Murashita T; Sugiki H; Kamikubo Y; Yasuda K
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1104-11. PubMed ID: 15541970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of prosthetic heart valve infection].
    Shevchenko IuL; Khubulava GG; Belevitin AB; Matveev SA; Cherepanin IM
    Vestn Khir Im I I Grek; 1999; 158(3):53-6. PubMed ID: 10481885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic valve endocarditis. Determinants of early survival and late morbidity.
    Aranki SF; Santini F; Adams DH; Rizzo RJ; Couper GS; Kinchla NM; Gildea JS; Collins JJ; Cohn LH
    Circulation; 1994 Nov; 90(5 Pt 2):II175-82. PubMed ID: 7955248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy and prevention of infectious endocarditis].
    Horstkotte D; Rosin H
    Schweiz Med Wochenschr; 1984 Nov; 114(45):1575-86. PubMed ID: 6515354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia.
    El-Ahdab F; Benjamin DK; Wang A; Cabell CH; Chu VH; Stryjewski ME; Corey GR; Sexton DJ; Reller LB; Fowler VG
    Am J Med; 2005 Mar; 118(3):225-9. PubMed ID: 15745719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus capitis prosthetic valve endocarditis: report of two rare cases and review of literature.
    Nalmas S; Bishburg E; Meurillio J; Khoobiar S; Cohen M
    Heart Lung; 2008; 37(5):380-4. PubMed ID: 18790338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus capitis endocarditis due to a transvenous endocardial pacemaker infection: case report and review of Staphylococcus capitis endocarditis.
    Cone LA; Sontz EM; Wilson JW; Mitruka SN
    Int J Infect Dis; 2005 Nov; 9(6):335-9. PubMed ID: 16085441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment outcome of prosthetic valve endocarditis].
    Abramczuk E; Rawczyńska-Englert I; Grabowski M; Jarnicka W
    Przegl Lek; 2003; 60(9):549-52. PubMed ID: 15065330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Staphylococcus aureus prosthetic valve endocarditis.
    Hassoun A
    Am J Med; 2007 Mar; 120(3):e9; author reply e11. PubMed ID: 17349434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.